ES463723A1 - Procedimiento para la obtencion de derivados del acido 13- tiaprostanico. - Google Patents

Procedimiento para la obtencion de derivados del acido 13- tiaprostanico.

Info

Publication number
ES463723A1
ES463723A1 ES463723A ES463723A ES463723A1 ES 463723 A1 ES463723 A1 ES 463723A1 ES 463723 A ES463723 A ES 463723A ES 463723 A ES463723 A ES 463723A ES 463723 A1 ES463723 A1 ES 463723A1
Authority
ES
Spain
Prior art keywords
translation
procedure
acid
machine
legally binding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES463723A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Publication of ES463723A1 publication Critical patent/ES463723A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22—Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0033—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing sulfur
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/32—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/04—Compounds containing oxirane rings containing only hydrogen and carbon atoms in addition to the ring oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/18—Radicals substituted by singly bound hetero atoms other than halogen by sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Procedimiento para la obtención de derivados del ácido 13-tiaprostánico de fórmula general I: ***(ver fórmula) donde A significa -CO- o -CHOH-, B significa -CH2-CH2 o -CH=CH-, R1 significa H o alquilo con 1 a 4 átomos de carbono, m significa un número entero entre 0 y 5, n significa un número entero entre 0 y 3, o, cuando B es -CH=CH-, también 4,5,6,7,8,ó 9, R2 significa alcoxi con 1 a 4 átomos de carbono, fenoxi, piridilo, tienilo, naftilo, fenilo sustituido por F, Cl, Br, OH, OCH3 CF3 o fenoxi sustituido por F, Cl, Br, OH, OCH3, CH3, ó CF3, o, cuando es -CH=CH-, también hidrógeno, fenilo o Tololo, y R3 significa H, metilo o etilo.
ES463723A 1975-11-07 1977-10-31 Procedimiento para la obtencion de derivados del acido 13- tiaprostanico. Expired ES463723A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2550004A DE2550004C2 (de) 1975-11-07 1975-11-07 Thiaprostaglandine sowie Verfahren zu ihrer Herstellung

Publications (1)

Publication Number Publication Date
ES463723A1 true ES463723A1 (es) 1978-06-16

Family

ID=5961171

Family Applications (2)

Application Number Title Priority Date Filing Date
ES453043A Expired ES453043A1 (es) 1975-11-07 1976-11-05 Procedimiento para la obtencion de derivados del acido 13- tiaprostanico.
ES463723A Expired ES463723A1 (es) 1975-11-07 1977-10-31 Procedimiento para la obtencion de derivados del acido 13- tiaprostanico.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES453043A Expired ES453043A1 (es) 1975-11-07 1976-11-05 Procedimiento para la obtencion de derivados del acido 13- tiaprostanico.

Country Status (7)

Country Link
JP (1) JPS6032625B2 (es)
CA (1) CA1072549A (es)
CH (1) CH625211A5 (es)
DE (1) DE2550004C2 (es)
ES (2) ES453043A1 (es)
NL (1) NL7612320A (es)
SE (1) SE7612368L (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3025325A1 (de) * 1980-07-04 1982-02-04 Merck Patent Gmbh, 6100 Darmstadt Neue 13-thiaprostaglandin-zwischenprodukte, verfahren zu ihrer herstellung und ihre verwendung zur herstellung von 13-thiaprostaglandin-derivaten
DE3401542A1 (de) * 1984-01-18 1985-08-01 Merck Patent Gmbh, 6100 Darmstadt Schwefelhaltige 6-ketoprostaglandine
JP2696933B2 (ja) * 1987-06-16 1998-01-14 日産化学工業株式会社 置換環状ケトン及び置換環状エノン並びにそれらの製造法
US5227505A (en) * 1987-06-16 1993-07-13 Nissan Chemical Industries, Ltd. Substituted cyclic ketones, substituted cyclic enones, and process for producing the same
US5254708A (en) * 1987-06-16 1993-10-19 Nissan Chemical Industries, Ltd. Substituted cyclic ketones, substituted cyclic enones, and process for producing the same
US5231208A (en) * 1987-06-16 1993-07-27 Nissan Chemical Industries, Ltd. Substituted cyclic ketones, substituted cyclic enones, and process for producing the same
WO1998039293A2 (en) * 1997-03-07 1998-09-11 Alcon Laboratories, Inc. 13-thia prostaglandins for use in glaucoma therapy

Also Published As

Publication number Publication date
JPS5259138A (en) 1977-05-16
JPS6032625B2 (ja) 1985-07-29
CA1072549A (en) 1980-02-26
DE2550004C2 (de) 1984-04-26
NL7612320A (nl) 1977-05-10
CH625211A5 (en) 1981-09-15
DE2550004A1 (de) 1977-05-18
SE7612368L (sv) 1977-05-08
ES453043A1 (es) 1977-12-16

Similar Documents

Publication Publication Date Title
ES462061A1 (es) Un procedimiento para la preparacion de nuevos derivados de tetrahidroisoquinoleina.
ES456279A1 (es) Un procedimiento para preparar compuestos de cetofosfonato.
ES463723A1 (es) Procedimiento para la obtencion de derivados del acido 13- tiaprostanico.
ES446534A1 (es) Procedimiento para la obtencion de nuevos derivados de acido13-tiaprostanico.
ES457993A1 (es) Un procedimiento para la preparacion de una isotiazolopiri- dina.
ES462662A1 (es) Procedimiento de preparacion del acido (fenil-3-amino-2-pro-pioniloxi)-2-acetico.
ES472511A1 (es) Procedimiento para la obtencion de derivados del acido 13 tianoprostanico
ES464045A1 (es) Un procedimiento para la produccion de una gamma-pirona.
ES472276A1 (es) Un procedimiento para la preparacion de un grupo de cis-4a- aril-octahidro-1h-2-pirindinas 2-sustituidas
ES451466A1 (es) Procedimiento para la preparacion de nuevos derivados de 5- tiazol-metanoamina.
ES458021A1 (es) Procedimiento para la obtencion de derivados de acido pros- tanoico.
JPS5573677A (en) Thienylbenzoic acid derivative and its production
ES441257A1 (es) Procedimiento para preparar aminocicloles.
ES459871A1 (es) Procedimiento para la obtencion de sales de hidrocarbil-tio-etilaminas.
ES460297A1 (es) Un compuesto.
ES462647A1 (es) Procedimiento para preparar derivados de benzociclohepteno.
ES442612A1 (es) Procedimiento para la obtencion de nuevos derivados de iso- quinoleina.
ES443610A1 (es) Procedimiento para preparar derivados de isoquinolina.
ES445253A1 (es) Un procedimiento para la preparacion de nuevos compuestos fenoxialilicos hipolipidemicos.
ES451741A2 (es) Procedimiento para preparar derivados de naftiridina.
ES446189A1 (es) Un metodo para preparar nuevos compuestos de oxima-eter.
ES437041A1 (es) Un procedimiento para preparar derivados de 1-ftalazona.
ES344990A1 (es) Procedimiento para la obtencion de nuevos 1-fenoxi-2-ami- noalcanos sustituidos.
ES324040A1 (es) Procedimiento para la produccion de derivados de la sulfonamidoquinazolina.
ES385679A1 (es) Un procedimiento para la preparacion de derivados de n-ari-lideno de compuestos de eritromicilamina.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20100623